1 / 16
People queue outside a private coronavirus disease (COVID-19) testing facility, amid the COVID-19 outbreak, in central London, Britain, January 2, 2022. REUTERS/Henry Nicholls
2 / 16
Girls gesture after receiving a dose of Bharat Biotech's COVID-19 vaccine, Covaxin, during a vaccination drive for children aged 15-18 in Mumbai, India, January 3, 2022. REUTERS/Niharika Kulkarni
3 / 16
People wait to receive the booster vaccine against the coronavirus disease (COVID-19) at a vaccination centre in Berlin, Germany, January 1, 2022. REUTERS/Michele Tantussi
4 / 16
A girl receives a dose of Covaxin, a coronavirus disease (COVID-19) vaccine manufactured by Bharat Biotech, during a vaccination drive for children aged 15-18 in New Delhi, India, January 3, 2022. REUTERS/Adnan Abidi
5 / 16
Children wait in queues to receives a dose of Bharat Biotech's COVID-19 vaccine, Covaxin, during a vaccination drive for children aged 15-18 in Mumbai, India, January 3, 2022. REUTERS/Niharika Kulkarni
6 / 16
A woman wearing a protective mask walks through a platform of a train station during the afternoon rush hours as the Omicron variant continues to spread, amid the coronavirus disease (COVID-19) pandemic, in Jakarta, Indonesia, January 3, 2022. REUTERS/Willy Kurniawan
7 / 16
Medical staff conducts a COVID-19 rapid test on a woman as others wait in a queue in Athens, Greece, Monday, Jan. 3, 2022. Omicron is now the dominant variant in terms of new infections, as the daily number of COVID-19 cases remain high in the country. (AP Photo/Thanassis Stavrakis)
8 / 16
A boy receives a dose of the COVAXIN coronavirus disease (COVID-19) vaccine manufactured by Bharat Biotech, during a vaccination drive for children aged 15-18 in New Delhi, India, January 3, 2022. REUTERS/Adnan Abidi
9 / 16
People wearing protective masks walk through a platform of a train station during the afternoon rush hours as the Omicron variant continues to spread, amid the coronavirus disease (COVID-19) pandemic, in Jakarta, Indonesia, January 3, 2022. REUTERS/Willy Kurniawan
10 / 16
Rupali Deshraj Nirmal, 16, reacts as she receives a dose of Bharat Biotech's COVID-19 vaccine, Covaxin, during a vaccination drive for children aged 15-18 in Mumbai, India, January 3, 2022. REUTERS/Niharika Kulkarni
11 / 16
A girl holding her mother reacts while receiving a dose of vaccine against the coronavirus disease (COVID-19) during a mass vaccination program for children aged 6-12 years, in Karawang, West Java province, Indonesia, January 3, 2022, in this photo taken by Antara Foto. M Ibnu Chazar/Antara Foto via REUTERS ATTENTION EDITORS - THIS IMAGE HAS BEEN SUPPLIED BY A THIRD PARTY. MANDATORY CREDIT. INDONESIA OUT. NO COMMERCIAL OR EDITORIAL SALES IN INDONESIA.
12 / 16
A sample is dripped into a COVID-19 lateral flow self testing kit, amid the coronavirus disease (COVID-19) outbreak in Manchester, Britain, January 3 , 2022. REUTERS/Phil Noble
13 / 16
FILE PHOTO: People wait in long lines at the Indianapolis Motor Speedway for coronavirus disease (COVID-19) testing and vaccines, as the Omicron variant continues to spread in Indianapolis, Indiana, U.S., December 29, 2021. Picture taken with a drone. REUTERS/Cheney Orr/File Photo
14 / 16
A girl reacts as she receives a dose of Bharat Biotech's coronavirus disease (COVID-19) vaccine, Covaxin, during a vaccination drive for children aged 15-18 years in Ahmedabad, India, January 3, 2022. REUTERS/Amit Dave TPX IMAGES OF THE DAY
15 / 16
A boy uses a COVID-19 lateral flow self testing kit ahead of returning to school, amid the coronavirus disease (COVID-19) outbreak in Manchester, Britain, January 3 , 2022. REUTERS/Phil Noble
16 / 16
Free antigen self-test kits on display at the doorway of a local government building, amid the coronavirus disease (COVID-19) outbreak, in London, Britain, January 3, 2022. REUTERS/Henry Nicholls
